Skip to main content

Table 11 Sensitivity analysis results for a time horizon of 1 year

From: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis

 

Diagnostic tests* after the first HPV test, n = 

Costs, €

Additional tests* versus Aptima, n = 

Additional costs versus Aptima, €

Aptima® HPV

782,718

10,531,090.77 €

–

–

Hybrid Capture® 2

969,205

391,950,533.69 €**

186,486

381,419,442.92 €

Cobas® 4800

968,365

13,027,190.26 €

185,647

2,495,928.49 €

  1. *Includes cytology, colposcopy, and biopsy
  2. **Includes HPV tests and other diagnostic tests (cytology, colposcopy, and biopsy)
  3. Includes the cost of HPV genotyping after the first and subsequent Hybrid Capture® 2 tests
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us